department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE · pharmadog

pharmadog
drugs
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE

drug

patient view →

EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE

updated 2mo ago

by Macleods Pharmaceuticals Ltd

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE

generic

EMTRICITABINE

Data sources

ClinicalTrials.gov

last refreshed 22m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 6

drugEMTRICITABINE, RILPIVIRINE, AND TENOFOVIR ALAFENAMIDE12 co-mentions · 3 sources
tagApproval12 co-mentions · 3 sources
drugemtricitabine12 co-mentions · 3 sources
tagSmall Molecule6 co-mentions · 3 sources
drugtenofovir alafenamide4 co-mentions · 2 sources
drugTENOFOVIR DISOPROXIL FUMARATE2 co-mentions · 1 sources

Trials studying EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE

phase3A Study to Evaluate the Efficacy, Safety, and Tolerability of Using an Oral Once-daily 2 Drug Regimen Compared to an Oral Once-daily 3 Drug Regimen for the Treatment of Human Immunodeficiency Virus (HIV)-1 in Adults Who Have Not Previously Taken Antiretroviral Therapyactive not recruitingn=307
phase3A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)recruitingn=4,580
phase1A Clinical Trial of MK-4646 With Bictegravir/Emtricitabine/Tenofovir Alafenamide and Dolutegravir in Healthy Adult Participants (MK-4646)not yet recruitingn=16
phase3Study of Oral Weekly Lepetegravir (Formerly GS-1720) and Lenacapavir Pacfosacil (Formerly GS-4182) Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressedactive not recruitingn=675
phase3Study of Oral Weekly GS-1720 and GS-4182 Compared With Biktarvy in People With HIV-1 Who Have Not Been Treatedterminatedn=73
phase3Intensification With Enfuvirtide in Naive HIV-infected Patients (ANRS130)completedn=195
phase2Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once Daily Combined With Norvir and Truvadacompletedn=35
—Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Preventionrecruitingn=3,000

more trials →